Design, construct, and evaluate Pseudomonas putida strains for targeted metabolite overproduction.
From in silico pathway design to production strain delivery and analytical validation.
Combining computational design, genetic modification, and process development to create high-performance Pseudomonas cell factories.
We use genome-scale metabolic models to design synthetic pathways that channel carbon flux toward your target compound, considering host metabolism and redox balance.
Using CRISPR-Cas9 tools adapted for Pseudomonas putida, we precisely edit the genome to introduce pathway genes, delete competing routes, and tune expression levels.
Evaluate media composition, induction strategies, and bioreactor conditions to evaluate product titer and yield.
Confirm strain identity, quantify metabolites via LC-MS/GC-MS, and assess by-product profiles for process consistency.
Transition from shake flasks to bench-scale bioreactors with process monitoring and parameter refinement.
Comprehensive documentation and materials for downstream development.
Each project is customized based on target compound, pathway complexity, and required validation depth.
| Parameter | Typical project scope |
|---|---|
| Target Compound | Specified by client; preliminary feasibility assessment included |
| Host Strain | Pseudomonas putida KT2440 or alternative (client-provided) |
| Pathway Design | In silico modeling and gene selection; iterative optimization |
| Editing Method | CRISPR-Cas9 (single gene or multiplex as scoped) |
| Flask Fermentation Screening | Multiple conditions tested; analytical sampling |
| Scale-Up | Up to 5 L bioreactor (scope-dependent) |
| QC & Validation | PCR, sequencing, and analytical chromatography |
A structured process ensuring reliable strain development with clear milestones.
We evaluate the base Pseudomonas putida strain and characterize its native metabolism to identify optimal engineering targets and integration sites.
Based on your target compound, we design the heterologous pathway, perform codon optimization, and synthesize the required gene cassettes for transformation.
Using CRISPR-Cas9, we introduce pathway genes and delete competing routes. Transformants are screened via PCR and sequencing to confirm correct integration.
We analyze intracellular metabolite pools and carbon flux to identify bottlenecks, then evaluate media composition and induction conditions for improved production.
The engineered strain is tested in controlled shake-flask and bioreactor experiments. Process parameters are refined for scalability and reproducibility.
Supporting a wide range of industries from chemical intermediates to environmental biotechnology.
Engineer Pseudomonas putida to produce fine chemicals, monomers, and bioplastics from renewable feedstocks. Our service helps reduce reliance on petrochemical routes.
Target complex natural product precursors and chiral intermediates. We design pathways that leverage Pseudomonas native robustness to achieve commercially relevant titers.
Evaluate the innate biodegradative capabilities of Pseudomonas putida for degradation of pollutants, including aromatics and recalcitrant compounds.
Clarifying scope, timelines, and technical expectations.
Our standard host is Pseudomonas putida KT2440, a well-characterized industrial chassis. We can also work with other P. putida strains or related pseudomonads upon request. Strain selection is evaluated during the initial consultation based on your target compound and process requirements.
Project timelines depend on pathway complexity and the number of genetic modifications. A typical single-gene knockout or simple pathway introduction ranges from 12 to 16 weeks from design to validated strain. More complex projects with multiplex edits and fermentation optimization may require longer, as scoped in the project proposal.
We employ a combination of DNA sequencing (for genetic fidelity), liquid chromatography/tandem mass spectrometry (LC-MS/MS) for metabolite quantification, and gas chromatography (GC) for volatile compounds. Flux analysis uses isotopic labeling to track carbon distribution. All methods are documented in the final report.
Yes, we routinely handle confidential projects. We can sign non-disclosure agreements (NDAs) and work under a material transfer agreement (MTA) to protect your intellectual property. Detailed management of your compounds and data is included in the project scope.
Get a customized quote for your Pseudomonas Metabolic Engineering Services project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.